Preparation, characterisation, and in vitro cancer‐suppression function of RNA nanoparticles carrying miR‐301b‐3p Inhibitor

BACKGROUND: Multidrug resistance is the biggest barrier on the way to chemotherapy for lung adenocarcinoma (LUAD). For some LUAD patients with cisplatin (DDP) resistance and poor prognoses, the authors put forward RNA nanoparticles (NPs) carrying miR‐301b‐3p Inhibitor. METHODS: The NPs were composed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Junjie, Niu, Niu, Yang, Fan, Liu, Haitao, Qi, Weibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190642/
https://www.ncbi.nlm.nih.gov/pubmed/36892102
http://dx.doi.org/10.1049/nbt2.12120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190642/
https://www.ncbi.nlm.nih.gov/pubmed/36892102
http://dx.doi.org/10.1049/nbt2.12120

Ejemplares similares